In Patients Receiving Pembrolizumab, Adverse Effects on the Pituitary Gland, Heart and Kidneys Must be Excluded

Internal Medicine

Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918

In Patients Receiving Pembrolizumab, Adverse Effects on the Pituitary Gland, Heart and Kidneys Must be Excluded

Josef Finsterer

著者情報

キーワード: renal cell carcinoma, pembrolizumab, hypopituitarism, myocarditis, renal insufficiency

ジャーナルオープンアクセス早期公開

論文ID: 5463-25

DOI https://doi.org/10.2169/internalmedicine.5463-25

詳細

記事の1ページ目

著者関連情報

© 2025 by The Japanese Society of Internal Medicine

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/

お気に入り & アラート

関連記事

閲覧履歴

前身誌

Japanese Journal of Medicine

Top